Skip to main content

Table 8 Incremental cost-effectiveness ratio of PEMF vs. standard treatment for acute scaphoid fractures

From: Functional outcome and cost-effectiveness of pulsed electromagnetic fields in the treatment of acute scaphoid fractures: a cost-utility analysis

 

Costs*

QALY

ICER

Group A (Active)

€2827

0.84

 

Group B (Placebo)

€2253

0.8545

 

Increment

€574

-0.0145

inferior

  1. *Costs are denoted in Euro.
  2. QALY, quality adjusted life year; ICER, incremental cost-effectiveness ratio.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us